Markets

  1. Home
Market Nav

HIKAL LTD.

  • NSE CodeHIKALEQ
  • BSE Code524735
  • ISININE475B01022
  • IndustryPharmaceuticals

Company Information

Management

Jai Hiremath

Executive Chairman

Incorporation Year

08/07/1988

Registered Address


Mumbai, Maharashtra - 400021
Tel: 022-62770299
Fax: 022-22833913

Registrar Office

MUFG Intime India Pvt. Ltd.
C 101, 247 Park, L.B.S. Marg, Vikhroli (West)
Mumbai,400083,Maharashtra
Tel: 022-49186270
Fax: 49186060

Email

info@hikal.com

Website

http://www.hikal.com

Listing

BSE, MCXSX, NSE

Corporate News

Hikal - Analysts/Institutional Investor Meet/Con. Cal...

04-Feb-2026|5:05PM

Hikal Limited has informed the Exchange about Schedule of meet

Hikal - Announcement under Regulation 30 (LODR)-Analy...

04-Feb-2026|5:02PM

Intimation of Earnings group conference call to discuss the financial and o

Hikal - Board Meeting Intimation for Approval Of Unau...

04-Feb-2026|4:55PM

Hikal Ltdhas informed BSE that the meeting of the Board of Directors of the

Hikal Ltd. has submitted to BSE the Shareholding Patt...

16-Jan-2026|6:00PM

As of December 2025, 68.85% is owned by Indian Promoters and 31.15% by Publ

More

Share Holding Pattern

Peer Comparison

Company NamePrice (₹)Market Cap(₹ Cr)
Aarey Drug65.33185.24
Aarti Drug379.503,463.70
Aarti Pharma764.406,929.08
Abbott India27,295.0057,999.97
Accent Micro335.60805.07
More

MF Holding

Scheme NameValue
(₹ Cr)		Holding (%)
Tata Sm..74.850.66
ICICI P..72.951.13
Tata In..8.930.68
Motilal..2.920.11
Motilal..0.020.06
More

Board Meetings

DatePurpose
11/02/2026Quarterly Results &..
13/11/2025Quarterly Results
07/08/2025Quarterly Results
14/05/2025Audited Results & F..
04/02/2025Quarterly Results &..
More